Kempner Capital Management Inc. Amgen Inc Transaction History

Kempner Capital Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $511 - $576	-2 Reduced 0.04%	4,691 $1.35 Million
Q4 2022 Jan 13, 2023	SELL	$229.03 - $291.01 $1.06 Million - $1.35 Million	-4,646 Reduced 49.75%	4,693 $0
Q1 2022 Apr 13, 2022	BUY	$219.27 - $242.57 $3,727 - $4,123	17 Added 0.18%	9,339 $2.26 Million
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $1.85 Million - $2.12 Million	9,322 New	9,322 $2.1 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Kempner Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Kempner Capital Management Inc. with notifications on news.